Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples

by Chunxiao Fu, Michal Marczyk, Michael Samuels, Alexander J. Trevarton, Jiaxin Qu, Rosanna Lau, Lili Du, Todd Pappas, Bruno V. Sinn, Rebekah E. Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans
Published 2021-02-01

CBCT-Based Adaptive Assessment Workflow for Intensity Modulated Proton Therapy for Head and Neck Cancer

by De Ornelas Mariluz, PhD, Yihang Xu, MS, Kyle Padgett, PhD, Ryder M. Schmidt, MS, Michael Butkus, PhD, Tejan Diwanji, MD, Gus Luciani, Jason Lambiase, Stuart Samuels, MD, PhD, Michael Samuels, MD, Nesrin Dogan, PhD
Published 2021-03-01